問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
李柏昕
下載
2022-02-01 - 2028-02-15
Condition/Disease
Test Drug
Participate Sites7Sites
Recruiting7Sites
2022-11-15 - 2034-07-12
2020-03-10 - 2027-03-31
Participate Sites5Sites
Recruiting5Sites
2022-06-01 - 2027-07-30
Participate Sites6Sites
Recruiting6Sites
2024-04-01 - 2029-08-31
Participate Sites8Sites
Not yet recruiting1Sites
2025-04-01 - 2033-01-20
Participate Sites9Sites
Recruiting9Sites
2022-03-01 - 2026-12-31
2022-05-10 - 2027-07-31
2022-02-28 - 2026-12-10
Advanced Non-small Cell Lung Cancer、EGFR Mutation、HER2 Mutation
BAY 2927088
Not yet recruiting2Sites
Recruiting2Sites
Terminated3Sites
全部
